What Are Compounded Medications? ImprimisRx® Breaks Down the Function and Importance of These Unique Pharmaceuticals

Compounded medications deliver active ingredients in a form that best meets the needs of the patient. ImprimisRx takes the benefits of traditional compounding for ophthalmic patients two steps further and eliminates pickup hassles and lowers costs.

Why would patients with the most common eye diseases of aging prefer compounded drugs from ImprimisRx? Why would physicians prefer to deal with ImprimisRx? Here are some examples.

Sublingual Sedation. Many patients are afraid of needles. They are especially afraid of needles in their eyes. ImprimisRx offers an alternative.

The ImprimisRx MKO melt is a non-addictive, non-opioid, lemon-flavored under-the-tongue compounded formulation for conscious sedation during cataract surgery and other ocular procedures. A combination of midazolam and ketamine HCl produces a state of relaxation and blocks pain, while ondansetron blocks postoperative nausea.

This ImprimisRx compounded product eliminates the need for IVs to administer anesthetic. It eliminates the sticking point of ‘finding a vein,” and reduces the time the patient needs to spend in the OR.

ImprimisRx provides sublingual sedation in bulk to physicians and clinics. There is no need for individual prescriptions.

Dropless® Formulations. Every year, cataract surgery saves the sight of three million eyes in the United States alone. The operation itself, however, requires some aftercare.

Preventing an inflammatory condition called pseudophakic cystoid macular edema (PCME) requires a combination of steroid and NSAID treatment for one to three months. The traditional route of administration for these drugs is eye drops.

And Many patients just don’t want to put drops in their eyes one to four times a day for up to three months. As a result, up to 60% of patients, depending on the technique, develop some measurable degree of vision loss due to PCME.

ImprimisRx offers a solution to the real problem of patient compliance: Dropless formulations.

Dropless formulations by ImprimisRx are compounded combinations of NSAID, steroid, and antibiotic medications intended for intracameral injection at the time of cataract surgery.to minimize or eliminate the need for patient self-administration of postoperative drops.

Problems with patient compliance are eliminated. Optimal treatment is assured at the time of surgery.

Some patients including those with diabetes and those who take high-dose aspirin, blood thinners, or fish oil, may need additional surveillance after the procedure. When the physician determines that additional prevention of inflammation is needed, ImprimisRx Less Drops® provide corticosteroid, nonsteroidal anti-inflammatory (NSAID), and antibiotic agents in the same bottle for easier compliance.

Klarity-C from ImprimisRx also addresses the problem of dry eyes with cyclosporine medication delivered in a way that reduces the doctor’s administrative burden. Said ImprimisRx President John Saharek:

“We developed Klarity-C as a preservative-free, easy-to-use, affordable option requiring no prior authorizations by insurance companies, no rebate forms, and no manufacturer coupons. We believe this product, supported by a clinical study published in Clinical Ophthalmology by three renowned ophthalmologists with expertise with dry disease, confirms the reported positive experiences of the tens of thousands of patients who have been prescribed Klarity-C.”

ImprimisRx operates on the principle that sometimes less is more. Less insurance paperwork, less patient compliance worries, and less confusing packaging provide a better patient experience with easier administration for the healthcare provider. ImprimisRx provides over 40 proprietary ophthalmic formulations to thousands of ophthalmologists and optometrists in all 50 states.

Sources: